| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18783318 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 105 journal articles in the PubMed database | Email to a friend | | |
| Landovitz RJ, Angel JB, Hoffmann C, et al.
Phase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment-Naive Subjects with HIV-1 Infection. [JOURNAL ARTICLE]
J Infect Dis 2008 Oct 15; 198(8):1113-1122.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Berenguer J, González J, Ribera E, et al.
Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903. [JOURNAL ARTICLE]
Clin Infect Dis 2008 Sep 9.
Abstract | Full Citation | | Saag MS, Tebas P, Sension M, et al.
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511). [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
AIDS 2001 Oct 19; 15(15):1971-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Staszewski S, Keiser P, Montaner J, et al.
Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
JAMA 2001 Mar 7; 285(9):1155-63.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ruane P, Lang J, Dejesus E, et al.
Pilot Study of Once-Daily Simplification Therapy with Abacavir/Lamivudine/Zidovudine and Efavirenz for Treatment of HIV-1 Infection. [Journal Article]
HIV Clin Trials 2006 Sep-Oct; 7(5):229-36.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ruane PJ, Parenti DM, Margolis DM, et al.
Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naïve HIV-infected adults. [Clinical Trial, Clinical Trial, Phase IV, Journal Article, Multicenter Study]
HIV Clin Trials 2003 Jul-Aug; 4(4):231-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
AIDS 2000 Mar 10; 14(4):367-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | DeJesus E, McCarty D, Farthing CF, et al.
Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Infect Dis 2004 Aug 1; 39(3):411-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Squires K, Lazzarin A, Gatell JM, et al.
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Acquir Immune Defic Syndr 2004 Aug 15; 36(5):1011-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
